BBVA Broker has been recognised in Spain in the first edition of the Estrategias de Inversión Awards, receiving top honours for platform security and customer service. The awards evaluated nearly ...

Loughborough University is collaborating with Northumbria University and the Football Supporters’ Association on the Safer Stadiums research initiative, which aims to improve safety and inclusivity ...

GH Research PLC is rated a Buy with $280.7M in cash, supporting lead candidate GH001 for Treatment-Resistant Depression. Read more on GHRS stock here.

"The significant asset growth in the Strategic Income Fund is a result of the Fund's very strong performance, whether in the intermediate or long-term," said North Square Co-Found ...

Initiated higher-dose CBeyond Expansion Study (Part C) to generate higher-exposure human safety and pharmacokinetic data with 400 mg and 600 mg ...

Under the Repurchase Program, as amended, we may repurchase up to an aggregate of $725.0 million of shares of our outstanding Class A common stock, par value $0.001 per share ("Class A Common Stock"), ...

The Central Board of Secondary Education (CBSE) conducted the Class 12 Mathematics exam on Monday (March 9). The exam was held from 10.30 am to 1.30 pm for CBSE students across India. Students and ...

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...

Early GO decision reached in CAPTIVATE ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned ...

Goldman Sachs recently named several stocks the Wall Street colossus believes are a must-own as market fears rise. The ...

The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...

Compugen Ltd. (NASDAQ: CGEN) Q4 2025 Earnings Call Transcript March 2, 2026 Compugen Ltd. beats earnings expectations. Reported EPS is $0.6, expectations were $0.05.